Internal Medicine, Rheumatology · Opelousas, LA
NPI
1528346251
Since 2011
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3975 I 49 S Service Rd, Suite 200
Opelousas, LA, 70570
Phone (337) 594-3980
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
233 services
Medicare patients, 2024
94
Average age 65
Drug cost, 2024
$3.2M
1,500 prescriptions
Company payments, 2025
$453
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Supraja Yeturi was code 99215 (office e&m - established), 76 times for 56 patients. In total Supraja Yeturi billed 233 services in 10 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 76 | 56 | $95.21 | $7,236 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 65 | 57 | $12.46 | $810 |
| 99214 Office E&M - Established | Facility | 42 | 35 | $67.07 | $2,817 |
| 99205 Office E&M - New | Facility | 18 | 18 | $136.78 | $2,462 |
By year: 2022 $43K for 434 services; 2023 $13K for 152 services; 2024 $14K for 233 services.
Medicare prescription drug claims, 2024
In 2024, the drug Supraja Yeturi prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 253 prescriptions and refills. In total Supraja Yeturi wrote 1,500 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 253 | 346 | 63 | $7,089 |
| Mycophenolate Mofetil Generic | 166 | 177 | 29 | $41K |
| Allopurinol Generic | 96 | 157 | 18 | $616 |
| Methotrexate Methotrexate Sodium | 96 | 144 | 37 | $1,799 |
| Prednisone Generic | 96 | 111 | 28 | $356 |
| Orencia Clickject Abatacept | 54 | 54 | 12 | $303K |
| Rinvoq Upadacitinib | 48 | 48 | Under 11 | $300K |
| Xeljanz Xr Tofacitinib Citrate | 45 | 45 | Under 11 | $270K |
| Humira(Cf) Pen Adalimumab | 45 | 45 | Under 11 | $326K |
| Azathioprine Generic | 40 | 45 | 13 | $1,803 |
| Ofev Nintedanib Esylate | 37 | 37 | Under 11 | $518K |
| Alendronate Sodium Generic | 35 | 60 | 11 | $340 |
| Rasuvo Methotrexate/Pf | 34 | 34 | Under 11 | $19K |
| Gabapentin Generic | 33 | 36 | 11 | $248 |
| Enbrel Sureclick Etanercept | 29 | 29 | Under 11 | $240K |
Brand drugs: 495 claims; generic drugs: 1,005 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Supraja Yeturi $453 ($453 in general payments such as food, travel and fees) from 9 companies. The largest payer was Amgen Inc. with $147.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.